54.70000 USD
3.58
7.00%
Last update Dec 12, 3:59 PM EST
Market closed
Day range
51.26000
56.99000
Previous close
51.12000
Open
51.26000
Access this stock data via API
Subscribe
Nektar Therapeutics Inc.
54.70
3.58
7.00%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 98.4M 90.1M 92.1M 101.9M
Cost of revenue 30.7M 33.8M 21.6M 24.9M
Gross profit 67.7M 56.4M 70.4M 77.0M
Operating expense
Research & development 120.9M 114.2M 218.3M 400.3M
Selling general and admin 76.8M 77.4M 92.3M 122.8M
Other operating expenses
Operating income -129.9M -135.2M -240.2M -446.1M
Non operating interest income
Income 14.5M 19.0M 6.8M 2.7M
Expense 28.1M 25.3M 28.9M 47.3M
Other income expense 24.3M -134.7M -102.6M -32.6M
Pretax income -119.2M -276.3M -365.0M -523.3M
Tax provision -239K -200K 3.2M 557K
Net income -119.0M -276.1M -368.2M -523.8M
Basic EPS -8.7 -1.5 -2.0 -2.9
Diluted EPS -8.7 -1.5 -2.0 -2.9
Basic average shares 13.7M 190.0M 187.1M 183.3M
Diluted average shares 13.7M 190.0M 187.1M 183.3M
EBITDA -111.4M -114.6M -220.5M -453.8M
Net income from continuing op. -119.0M -276.1M -368.2M -523.8M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed (non-working day)
Pre-market opens in 15 hours 14 minutes

12:45
00:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).